Oncocyte Corp·4

Mar 28, 4:05 PM ET

Liu James Yang 4

4 · Oncocyte Corp · Filed Mar 28, 2025

Insider Transaction Report

Form 4
Period: 2025-03-26
Liu James Yang
VP ACCT, Cntlr, Treasurer, PAO
Transactions
  • Award

    Option to Purchase Common Stock

    2025-03-26+10,00010,000 total
    Exercise: $3.18Exp: 2035-03-26Common Stock (10,000 underlying)
  • Award

    Restricted Stock Units

    2025-03-26+18,86718,867 total
    Exercise: $0.00Common Stock (18,867 underlying)
Footnotes (2)
  • [F1]33 and 1/3% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.
  • [F2]33 and 1/3% of the restricted stock units will vest on each of the one-, two- and three-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary